Anti-thrombotics cause harm in the setting of stroke thrombectomy

Affiliations

¹ Department of Clinical Neurosciences, Department of Radiology, and Department of Community Health Sciences, Cumming School of Medicine, Hotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 1N4, Canada.
² Department of Clinical Neurosciences, Department of Radiology, and Department of Community Health Sciences, Cumming School of Medicine, Hotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 1N4, Canada. Electronic address: scoutts@ucalgary.ca.

Comment

Mohammed A Almekhlafi et al. Lancet. 2022.

. 2022 Mar 12;399(10329):1025-1026.

doi: 10.1016/S0140-6736(22)00335-X. Epub 2022 Feb 28.

¹ Department of Clinical Neurosciences, Department of Radiology, and Department of Community Health Sciences, Cumming School of Medicine, Hotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 1N4, Canada.
² Department of Clinical Neurosciences, Department of Radiology, and Department of Community Health Sciences, Cumming School of Medicine, Hotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 1N4, Canada. Electronic address: scoutts@ucalgary.ca.

No abstract available

Conflict of interest statement

We declare no competing interests.

Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial.
van der Steen W, van de Graaf RA, Chalos V, Lingsma HF, van Doormaal PJ, Coutinho JM, Emmer BJ, de Ridder I, van Zwam W, van der Worp HB, van der Schaaf I, Gons RAR, Yo LSF, Boiten J, van den Wijngaard I, Hofmeijer J, Martens J, Schonewille W, Vos JA, Tuladhar AM, de Laat KF, van Hasselt B, Remmers M, Vos D, Rozeman A, Elgersma O, Uyttenboogaart M, Bokkers RPH, van Tuijl J, Boukrab I, van den Berg R, Beenen LFM, Roosendaal SD, Postma AA, Krietemeijer M, Lycklama G, Meijer FJA, Hammer S, van der Hoorn A, Yoo AJ, Gerrits D, Truijman MTB, Zinkstok S, Koudstaal PJ, Manschot S, Kerkhoff H, Nieboer D, Berkhemer O, Wolff L, van der Sluijs PM, van Voorst H, Tolhuisen M, Roos YBWEM, Majoie CBLM, Staals J, van Oostenbrugge RJ, Jenniskens SFM, van Dijk LC, den Hertog HM, van Es ACGM, van der Lugt A, Dippel DWJ, Roozenbeek B; MR CLEAN-MED investigators. van der Steen W, et al. Lancet. 2022 Mar 12;399(10329):1059-1069. doi: 10.1016/S0140-6736(22)00014-9. Epub 2022 Feb 28. Lancet. 2022. PMID: 35240044 Clinical Trial.